Psychotherapy and psychopharmacology utilization following repetitive transcranial magnetic stimulation (rTMS) in patients with major depressive disorder

Autor: Jeffrey D. King, Stuart L. Lustig, Vikram N. Shah, Stephanie D. Mote, Priya Needs, Michael Manocchia, Debra D. Szuba
Rok vydání: 2019
Předmět:
Adult
Male
Psychotherapist
Psychopharmacology
medicine.medical_treatment
Population
Transcranial Direct Current Stimulation
behavioral disciplines and activities
03 medical and health sciences
0302 clinical medicine
mental disorders
Medicine
Humans
Antipsychotic
education
Biological Psychiatry
Depression (differential diagnoses)
education.field_of_study
Depressive Disorder
Major
business.industry
musculoskeletal
neural
and ocular physiology
Middle Aged
medicine.disease
Transcranial Magnetic Stimulation
Antidepressive Agents
030227 psychiatry
Transcranial magnetic stimulation
Psychotherapy
Psychiatry and Mental health
Treatment Outcome
nervous system
Major depressive disorder
Antidepressant
Population study
Female
business
psychological phenomena and processes
030217 neurology & neurosurgery
Antipsychotic Agents
Zdroj: Psychiatry research. 278
ISSN: 1872-7123
Popis: Lifetime prevalence of major depressive disorder (MDD) among a sample of adults in the United States has been reported as over 16%. Repetitive transcranial magnetic stimulation (rTMS) has become a treatment option for a subset of treatment-refractory patients with MDD. In a population of 159 commercial health plan individuals, we used claims data to compare utilization of antidepressants, antipsychotics, and psychotherapy during the one-year time period prior to rTMS initiation to the one-year time period starting 60 days after rTMS initiation. Both antidepressant and antipsychotic use declined significantly from three months pre-rTMS compared to each of four quarterly post-rTMS time points. Psychotherapy utilization also significantly declined post-rTMS compared to pre-rTMS. The reduction in medication utilization could reflect clinical improvement of the study population, and the absence of even greater reductions in utilization likely reflects the lack of clinical guidelines for antidepressant prescribing in the aftermath of rTMS treatment.
Databáze: OpenAIRE
Externí odkaz: